Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - EU Market Recap: FTSE 100 (0.13%) to 9479.14, DAX flat at 24378.29, CAC40 (1.36%) to 7971.78, STOXX 600 (0.04%) to 570.24

Oct 06 ,2025

  • Synopsis:

    • European equity markets mostly lower, well off worst levels. French CAC underperforms amid resignation of French PM Lecornu less than 24 hours after naming his cabinet. Energy, Technology and Insurance were the best performing sectors, Personal Goods, Banks and Chemicals lagged.

    • Political developments weighing on sentiment after French PM Lecornu resigned Monday, after naming cabinet on Sunday. 12 out of 18 members of his team unchanged from prior administrations and generated malcontent. Most senior members from the cabinet of ousted premier Bayrou were renamed to their posts. New finance minister Roland Lescure previously ran the industry portfolio.

    • Press discusses ECB leadership with Eurozone finance ministers to start considering successor to vice president de Guindos, which could shape search for next president with Lagarde's term to end in 2027.

    • Elsewhere, UK Treasury criticized wasteful spending after fiscal watchdog OBR provided first pre-budget update to Reeves on Friday.

    • Quiet macro calendar. Sentix survey showed improvement in Eurozone investor sentiment.

    • On the reporting front, among notable updates, SEB (SK.FP) now anticipates a slight organic decline in Q3 sales, resulting in results below forecasts, and FY operating results are revised to €550-600M, down from €700-750M. Further out of France, Compagnie de Saint-Gobain (SGO.FP) launches new strategic plan "Lead & Grow". Out of the UK, Mondi (MNDI.LN) shares are lower post Q3 trading update with company noting Q3 remained challenging. Aston Martin Lagonda Global Holdings (AML.LN) said it no longer expected to meet its previous FY25 wholesale volume guidance given Q3 performance and revised expectation for Q4 wholesales. Further in the auto sector, wires reported that Stellantis (STLAM.IM) is planning $10B in US turnaround investments. Out of DACHs, Redcare Pharmacy (RDC.GR) shares strong in early trading post better-than-expected preliminary Q3 revenue at €719M vs FactSet €715.2M. Hannover Re (HNR1.GR) also trading higher after announcing plans to increase its dividend to around 55% of IFRS Group net income, aiming to maintain and gradually grow dividend levels.

    • In M&A news, holder Daniel Kretinsky reportedly has agreed to sell his 20% stake in ThyssenKrupp (TKA.GR), paving the way for India's Jindal Steel talks; Euronext (ENX.FP) launcheed an offer for Hellenic Exchanges-Athens Stock Exchange (EXAE.GA) and - still in France - BNP Paribas (BNP.FP) completed the acquisition of HSBC private banking activities in Germany.

  • Digest:

    • Sectors - STOXX Europe 600:

      • Outperformers:

        • Oil & Gas +1.27%, Technology +1.01%, Insurance +0.90%, Basic Resources +0.55%, Health Care +0.43%, Autos & Parts +0.21%, Utilities +0.18%, Financial Svcs +0.13%, Telecom +0.04%

      • Underperformers:

        • Persnl & HHold Goods (1.24%), Banks (0.86%), Chemicals (0.77%), Construct & Mtls (0.72%), Media (0.51%), Ind Goods & Svcs (0.45%), Real Estate (0.32%), Food & Beverage (0.23%), Retail (0.16%), Travel & Leisure (0.13%)

    • Macro:

      • EU

        • EU watchdog to expand oversight of crypto and exchanges (FT)

      • ECB:

        • ECB faces major leadership overhaul by 2027 (Bloomberg)

      • UK:

        • UK plans to streamline home-buying process (Reuters)

        • UK new car sales posted strongest September since 2020 (ThisisMoney)

        • Kemi Badenoch pledges £47B in Tory spending cuts (FT)

        • UK drops China spying case to protect Beijing ties (FT)

        • Rachel Reeves eyes bank profit tax to plug budget gap (Inews)

        • UK Green leader seeks to redefine patriotism with wealth tax (Bloomberg)

      • France:

        • Macron's new French cabinet faces immediate no-confidence threat (Guardian, Politico)

      • Germany

        • Germany's defense minister pushes for state stake in industry (Bloomberg)

        • Germany upgrades economic growth forecasts for 2025-2027 (Bloomberg)

    • Company news:

      • Notable Gainers

        • +38.1% HSS.LN (HSS Hire Group £0.10, +0.03) -- FY earnings; ProService supply agreement with Speedy Hire; disposal of THSC

        • +19.1% SDY.LN (Speedy Hire £0.29, +0.05) -- FY earnings; ProService supply agreement with Speedy Hire; disposal of THSC

        • +11.4% RDC.GR (Redcare Pharmacy €87.05, +8.90) -- prelim. Q3 revenue

        • +10.1% ITM.LN (ITM Power £0.87, +0.08) -- Front-End Engineering Design (FEED) contract

        • +9.6% STX.LN (Shield Therapeutics £0.09, +0.01) -- Stifel upgrade

        • +9.1% QTX.LN (Quartix Technologies £3.11, +0.26) -- Q3 trading update

        • +5.8% ORNBV.FH (Orion €69.10, +3.80) -- Nordea upgrade

        • +4.5% AZA.SS (Avanza Bank Holding SEK365.00, +15.80) -- SEB upgrade; Kepler Cheuvreux upgrade

        • +3.9% BVC.LN (BATM Advanced Communications £0.19, +0.01) -- sale of its diagnostics distributor AMS at £17.6M

        • +3.4% AKRBP.NO (Aker BP NOK264.90, +8.60) -- Q3 production update

        • +3.3% MGN.NO (Magnora NOK22.20, +0.70) -- acquires majority stake in Storespeed AS

        • +3.2% HNR1.GR (Hannover Re €265.20, +8.20) -- changes dividend policy

        • +2.9% TET.LN (Treatt £2.81, +0.08) -- Natara increases recommended final cash offer at 290p/Treatt share

        • +2.6% KID.NO (Kid ASA NOK150.40, +3.80) -- Arctic Securities upgrade

        • +2.4% ACOMO.NA (ACOMO NV €23.70, +0.55) -- acquires Manuzzi S.r.l.

        • +1.5% RANA.NO (Rana Gruber NOK66.60, +1.00) -- Q3 production

      • Notable Decliners

        • -21.4% SK.FP (SEB €51.90, -14.15) -- lowers FY guidance; CIC Market Solutions downgrade

        • -16.0% MNDI.LN (Mondi £8.80, -1.67) -- Q3 earnings; JPMorgan downgrade

        • -10.1% AML.LN (Aston Martin Lagonda Global Holdings £0.73, -0.08) -- Q3 trading update; lowers FY outlook

        • -9.0% JLP.LN (Jubilee Metals Group £0.03, -0.00) -- Zambia copper strategy update on disposal of South Africa operating business

        • -6.0% QQ.LN (QinetiQ Group £5.04, -0.32) -- Kepler Cheuvreux downgrade

        • -5.8% EMBRAC.B.SS (Embracer Group SEK105.88, -6.48) -- Handelsbanken downgrade

        • -4.4% SFL.IM (Safilo Group €1.56, -0.07) -- Kepler Cheuvreux downgrade

        • French PM Lecornu resigns

          • -4.3% KOF.FP (Kaufman & Broad €27.90, -1.25)

          • -3.4% ELIS.FP (Elis €24.00, -0.84)

          • -3.4% ACA.FP (Credit Agricole €16.34, -0.58)

          • -3.2% BNP.FP (BNP Paribas €75.50, -2.50)

          • -3.0% AM.FP (Dassault Aviation €280.80, -8.80)

          • -2.7% GET.FP (Getlink €15.31, -0.42)

          • -2.4% SW.FP (Sodexo €53.45, -1.30)

          • -2.4% VIE.FP (Veolia Environnement €28.46, -0.70)

          • -2.1% VLA.FP (Valneva €4.87, -0.11)

          • -2.0% ELIOR.FP (Elior Group €2.79, -0.06)

          • -1.8% KER.FP (Kering €292.40, -5.45)

          • -1.6% RNO.FP (Renault €35.20, -0.58)

        • -4.2% INLOT.GA (Intralot €1.18, -0.05) -- prices 350M new share offering at €1.10/share

        • -4.0% FXPO.LN (Ferrexpo £0.51, -0.02) -- Q3 production

        • -2.5% ASHM.LN (Ashmore Group £1.80, -0.05) -- Barclays downgrade

        • -2.2% TCM.DC (TCM Group DKK70.80, -1.60) -- Bank of America discloses disposal of 11.54% stake held via financial instruments

    • EU companies reporting tomorrow:

      • Earnings:

        • France: Voyageurs du Monde (ALVDM.FP), Bilendi (ALBLD.FP)

        • UK: CVS Group (CVSG.LN)

      • Trading Update:

        • France: GenSight Biologics (SIGHT.FP)

      • Traffic: Finnair (FIA1S.FH)

      • CMD/Events: Sika (SIKA.SW) Innovation Lab, Biotalys (BTLS.BB) Flemish Retail Investor Assn

      • Analyst Meeting: Biotalys (BTLS.BB), Frequentis (FQT.GR),Givaudan (GIVN.SW),Maat Pharma (MAAT.FP)

  • Data:

    • Economics:

      • Denmark Aug Manufacturing Production (2.9%) m/m vs consensus (2.4%) and prior revised +1.4% from +1.2%

      • Spain Aug Industrial Production +3.4% y/y vs consensus +2.6% and prior revised +2.7% from +2.5%

      • Switzerland Sep Unemployment Rate (sa) 3.0% vs consensus 2.9% and prior 2.9%

      • Sep Construction PMI

        • Germany 46.2 vs consensus 46.6 and prior 46.0

        • UK 46.2 vs consensus 46.1 and prior 45.5

      • Eurozone Oct Sentix Investor Confidence (5.4) vs consensus (7.5) and prior (9.2)

    • Markets:

      • WTI Crude (Nov 25): +$0.85 or +1.40% to $61.73

      • €-$ (0.0025) or (0.22%) to 1.1704

      • £-$ +0.0020 or +0.15% to 1.3471

      • €-£ (0.0033) to 0.8689

      • S&P 500 +0.32%

      • Performance year-to-date

        • FTSE 100: +15.98%

        • DAX: +22.45%

        • CAC: +8.01%

        • MIB: +26.21%

        • Stoxx 600: +12.34%

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE